AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $205,091,507 | +4.8% | 2,934,490 | +7.7% | 0.01% | +20.0% |
Q2 2023 | $195,713,800 | +28.6% | 2,723,543 | +10.3% | 0.01% | +25.0% |
Q1 2023 | $152,240,056 | -21.1% | 2,468,224 | -1.4% | 0.00% | -33.3% |
Q4 2022 | $193,054,615 | +97.4% | 2,502,977 | +14.2% | 0.01% | +100.0% |
Q3 2022 | $97,819,000 | +14.6% | 2,192,255 | -1.7% | 0.00% | 0.0% |
Q2 2022 | $85,375,000 | -1.4% | 2,229,077 | +6.5% | 0.00% | +50.0% |
Q1 2022 | $86,600,000 | +8.7% | 2,092,257 | -0.8% | 0.00% | 0.0% |
Q4 2021 | $79,700,000 | +16.9% | 2,109,622 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $68,165,000 | -52.4% | 2,068,063 | -2.5% | 0.00% | -50.0% |
Q2 2021 | $143,067,000 | +8.9% | 2,120,754 | -8.6% | 0.00% | 0.0% |
Q1 2021 | $131,346,000 | -29.3% | 2,319,793 | +1.8% | 0.00% | -33.3% |
Q4 2020 | $185,733,000 | +15.2% | 2,279,766 | +0.7% | 0.01% | 0.0% |
Q3 2020 | $161,291,000 | -18.1% | 2,263,759 | -5.4% | 0.01% | -25.0% |
Q2 2020 | $196,934,000 | +48.5% | 2,393,467 | +6.2% | 0.01% | +33.3% |
Q1 2020 | $132,641,000 | -40.6% | 2,254,650 | +4.4% | 0.01% | -33.3% |
Q4 2019 | $223,283,000 | +509.2% | 2,160,246 | +19.3% | 0.01% | +350.0% |
Q3 2019 | $36,652,000 | -15.8% | 1,810,877 | +7.1% | 0.00% | 0.0% |
Q2 2019 | $43,531,000 | +557.1% | 1,690,522 | +263.1% | 0.00% | – |
Q1 2019 | $6,625,000 | +3560.2% | 465,587 | +626.9% | 0.00% | – |
Q4 2018 | $181,000 | -6.2% | 64,049 | +14.6% | 0.00% | – |
Q3 2018 | $193,000 | +12.2% | 55,912 | +4.1% | 0.00% | – |
Q2 2018 | $172,000 | +49.6% | 53,717 | +15.1% | 0.00% | – |
Q1 2018 | $115,000 | -56.6% | 46,659 | -1.4% | 0.00% | – |
Q4 2017 | $265,000 | +5.6% | 47,303 | +4.5% | 0.00% | – |
Q3 2017 | $251,000 | -2.3% | 45,263 | -2.9% | 0.00% | – |
Q2 2017 | $257,000 | -86.6% | 46,621 | -90.5% | 0.00% | – |
Q1 2017 | $1,917,000 | +63800.0% | 491,505 | +117204.3% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 419 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | 0.0% | 419 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | – | 419 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |